Drug Research
BioInvent extends research collaboration and license agreement with Pfizer Inc
BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc. until the end of 2020.
In December 2016, the companies entered into the agreement for the...
Drug Research
Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
Abbott and Tandem Diabetes Care announced that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems to provide more options for...
Drug Research
Stevanato Group signs an agreement with the CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development
Italy-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, and CEPI (the Coalition for Epidemic Preparedness Innovations) - the global partnership at the forefront of funding and coordinating the development of...
Drug Research
Biocair transports COVID-19 antibody tests for the German Football Association
As part of the agreement, Biocair will transport selected blood samples to specialist laboratories for investigation to find out if the individual has developed antibodies against the SARS-CoV-2 virus.
The Bundesliga was the first European football league to restart amidst...
Drug Research
Thermo Fisher and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer
Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher's next-generation sequencing (NGS)-based Oncomine Dx Target Test. The CDx will be designed to...
Drug Research
Piramal Pharma Announces Acquisition of Solid Oral Dosage Drug Product Facility in Pennsylvania from G&W Laboratories
Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a contract development and manufacturing organization, has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, PA. According to the...
Drug Research
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has signed an agreement with ViralClear Pharmaceuticals, Inc. (ViralClear), a subsidiary of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
